ARS PHARMACEUTICALS INC (SPRY:NASDAQ)
$5.72 0.37 (6.9159%)
Analysed ARS PHARMACEUTICALS INC (SPRY:NASDAQ) News Sources
SPRY, PASG, BOXL: Why These Stocks Plunged Double Digits In After-Hours Trading Today
25-06-2026
stocktwits.com
ARS Pharma Collapses After CVS Punts Its Epinephrine Spray Decision To January
25-06-2026
yahoo.com
ARS Pharmaceuticals (SPRY) Is Down 11.5% After Losing Spots in Key Russell 2000 Defensive Indices
29-06-2026
yahoo.com
ARS Pharmaceuticals Announces CEO Succession
07-07-2026
yahoo.com
ARS Pharmaceuticals (SPRY) Appoints Donn Casale As The New CEO
15-07-2026
yahoo.com
ARS Pharmaceuticals Announces Conference Call and Webcast on August 13 Outlining its Updated Strategic Priorities and Reporting Second Quarter 2026 Financial Results
03-08-2026
yahoo.com
ARS Pharmaceuticals Outlines Strategic Priorities, including a Focused Commercial Strategy, and Reports Second Quarter 2026 Financial Results
13-08-2026
yahoo.com
ARS Pharmaceuticals, Inc. (SPRY) Reports Q2 Loss, Tops Revenue Estimates
13-08-2026
yahoo.com
ARS Pharmaceuticals Q2 Earnings Call Highlights
14-08-2026
marketbeat.com
Can ARS Pharmaceuticals, Inc. (SPRY) Climb 297.02% to Reach the Level Wall Street Analysts Expect?
20-08-2026
yahoo.com
What is the current price of ARS PHARMACEUTICALS INC (SPRY:NASDAQ)?
The current price of ARS PHARMACEUTICALS INC (SPRY:NASDAQ) is $5.72.
ARS PHARMACEUTICALS INC (SPRY:NASDAQ) absolute price change since previous trading day?
The absolute price change of ARS PHARMACEUTICALS INC (SPRY:NASDAQ) since the previous trading day is $0.37.
ARS PHARMACEUTICALS INC (SPRY:NASDAQ) percentage price change since previous trading day?
The percentage price change of ARS PHARMACEUTICALS INC (SPRY:NASDAQ) since the previous trading day is 6.9159%.
What is the most recent average sentiment score for ARS PHARMACEUTICALS INC (SPRY:NASDAQ)?
The most recent average sentiment score for ARS PHARMACEUTICALS INC (SPRY:NASDAQ) is 60 out of 100.
What is the most recent average sentiment for ARS PHARMACEUTICALS INC (SPRY:NASDAQ)?
The most recent sentiment for ARS PHARMACEUTICALS INC (SPRY:NASDAQ) is .
SEC-8K** Filing Available For ARS PHARMACEUTICALS INC (SPRY:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.